The growing applications of synthetic biology is a major driver for the growth of this market.

By -

Synthetic Biology Market by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022

(EMAILWIRE.COM, October 22, 2019 ) In this report, the market is segmented by tool, technology, application, and region. On the basis tool, the synthetic biology market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. The chassis organisms segment is expected to grow at the highest rate during the forecast period. The increasing demand for green alternatives (biomass is converted to chemicals using engineered bacteria, yeasts, and other microorganisms) to fossil fuels is a key driver for this segment.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889

Some of The Major Players In Synthetic Biology Market:
1. Thermo Fisher (US)
2. Novozymes (Denmark)
3. Merck KGaA (Germany)
4. Intrexon (US)
5. Agilent Technologies (US)
5. Amyris (US)
6. GenScript (US)
7. Ginkgo Bioworks (US)
8. DNA Technologies (US)

According to the new market research report “Synthetic Biology Market” by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022", published by MarketsandMarkets™, The synthetic biology market is expected to reach USD 8.84 Billion by 2022 from an estimated USD 3.57 Billion in 2017, at a CAGR of 19.9%.

Get Sample Copy of This Report
@https://www.marketsandmarkets.com/requestsampleNew.asp?id=889

Synthetic Biology Market segmented into :

+ The global synthetic biology market is segmented on the basis of tool, technology, application, and region. Based on tools, the market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids.

+ By technology, the market is segmented into gene synthesis, genome engineering, cloning and sequencing, next-generation sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, and nanotechnology.

+ The market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), food & agriculture, and environmental (bioremediation and biosensing) on the basis of application.

Want Full Report? Inquire Here: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=889

Read other news from 360Quadrants

Indoor Farming Technology Market worth $32.3 billion by 2028

360Quadrants - Sep 15, 2023
The indoor farming technology market is projected to reach USD 32.3 billion by 2028 from USD 20.3 billion by 2023, at a CAGR of 9.7% during the forecast period in terms of value. ...Read more

Sherwin-Williams identified as a Market Leader in the “Top 16 Paints and Coatings Companies by MarketsandMarkets 360 Quadrant”

360Quadrants - Aug 10, 2023
Sherwin-Williams (USA), PPG Industries (USA), AkzoNobel (Netherlands), RPM Inc (USA), and Nippon Paints (Japan) are the top five leading companies in the paints and coatings industry and account for an approximate 35%-40% share of the ...Read more

Asian Paints identified as an Innovator in the “Top 16 Paints and Coatings Companies by MarketsandMarkets 360 Quadrant”

360Quadrants - Aug 08, 2023
The Paints and Coatings Quadrant is a comprehensive industry analysis that provides valuable insights into the global market for Paints and Coatings. This quadrant offers a detailed evaluation of key market players, technological advancements, product ...Read more